ATE397488T1 - Vorrichtung zur herstellung von liposomen - Google Patents

Vorrichtung zur herstellung von liposomen

Info

Publication number
ATE397488T1
ATE397488T1 AT99972124T AT99972124T ATE397488T1 AT E397488 T1 ATE397488 T1 AT E397488T1 AT 99972124 T AT99972124 T AT 99972124T AT 99972124 T AT99972124 T AT 99972124T AT E397488 T1 ATE397488 T1 AT E397488T1
Authority
AT
Austria
Prior art keywords
producing liposomes
liposomes
producing
therapeutic applications
mixing system
Prior art date
Application number
AT99972124T
Other languages
English (en)
Inventor
Martin Baker
William Heriot
Original Assignee
Heriot William A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heriot William A filed Critical Heriot William A
Application granted granted Critical
Publication of ATE397488T1 publication Critical patent/ATE397488T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying
    • B01F23/41—Emulsifying
    • B01F23/411—Emulsifying using electrical or magnetic fields, heat or vibrations
    • B01F23/4111—Emulsifying using electrical or magnetic fields, heat or vibrations using vibrations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying
    • B01F23/41—Emulsifying
    • B01F23/4105—Methods of emulsifying
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/80—Mixing plants; Combinations of mixers
    • B01F33/82—Combinations of dissimilar mixers
    • B01F33/821—Combinations of dissimilar mixers with consecutive receptacles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
    • B01F35/20—Measuring; Control or regulation
    • B01F35/21—Measuring
    • B01F35/213—Measuring of the properties of the mixtures, e.g. temperature, density or colour
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
    • B01F35/20—Measuring; Control or regulation
    • B01F35/22—Control or regulation
    • B01F35/221—Control or regulation of operational parameters, e.g. level of material in the mixer, temperature or pressure
    • B01F35/2215—Temperature
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
    • B01F35/80—Forming a predetermined ratio of the substances to be mixed
    • B01F35/83—Forming a predetermined ratio of the substances to be mixed by controlling the ratio of two or more flows, e.g. using flow sensing or flow controlling devices
    • B01F35/831—Forming a predetermined ratio of the substances to be mixed by controlling the ratio of two or more flows, e.g. using flow sensing or flow controlling devices using one or more pump or other dispensing mechanisms for feeding the flows in predetermined proportion, e.g. one of the pumps being driven by one of the flows
    • B01F35/8311—Forming a predetermined ratio of the substances to be mixed by controlling the ratio of two or more flows, e.g. using flow sensing or flow controlling devices using one or more pump or other dispensing mechanisms for feeding the flows in predetermined proportion, e.g. one of the pumps being driven by one of the flows with means for controlling the motor driving the pumps or the other dispensing mechanisms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2215/00—Auxiliary or complementary information in relation with mixing
    • B01F2215/04—Technical information in relation with mixing
    • B01F2215/0413—Numerical information
    • B01F2215/0436—Operational information
    • B01F2215/0468—Numerical pressure values
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2215/00—Auxiliary or complementary information in relation with mixing
    • B01F2215/04—Technical information in relation with mixing
    • B01F2215/0413—Numerical information
    • B01F2215/0436—Operational information
    • B01F2215/0472—Numerical temperature values
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99972124T 1998-11-13 1999-11-12 Vorrichtung zur herstellung von liposomen ATE397488T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10835598P 1998-11-13 1998-11-13

Publications (1)

Publication Number Publication Date
ATE397488T1 true ATE397488T1 (de) 2008-06-15

Family

ID=22321729

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972124T ATE397488T1 (de) 1998-11-13 1999-11-12 Vorrichtung zur herstellung von liposomen

Country Status (9)

Country Link
US (3) US6534018B1 (de)
EP (1) EP1146959B1 (de)
JP (1) JP2002529240A (de)
AT (1) ATE397488T1 (de)
AU (1) AU756196B2 (de)
CA (1) CA2350430C (de)
DE (1) DE69938875D1 (de)
IL (1) IL143104A (de)
WO (1) WO2000029103A1 (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0943242A1 (de) * 1998-02-26 1999-09-22 Puratos N.V. Granuliertes Brotvergesserungmittel sowie ihre Verwendung zur Herstellung von Teigwaren
US6855296B1 (en) * 1998-11-13 2005-02-15 Optime Therapeutics, Inc. Method and apparatus for liposome production
WO2000042990A1 (en) * 1999-01-25 2000-07-27 Optime Therapeutics, Inc. Liposome formulations
CN1228041C (zh) * 1999-07-15 2005-11-23 英耐克斯药品股份有限公司 脂质包埋的治疗剂的制备方法
US20020119188A1 (en) * 2000-02-08 2002-08-29 Susan Niemiec Method of manufacturing liposomes
EP1128185B8 (de) * 2000-02-25 2009-08-19 Hitachi, Ltd. Mischvorrichtung für Analysenautomat
EP1203614A1 (de) 2000-11-03 2002-05-08 Polymun Scientific Immunbiologische Forschung GmbH Verfahren und Vorrichtung zur Herstellung von Lipidvesikeln
DE60334618D1 (de) 2002-06-28 2010-12-02 Protiva Biotherapeutics Inc Verfahren und vorrichtung zur herstellung von liposomen
EP3427742B1 (de) 2002-10-29 2020-08-12 Insmed Incorporated Aminoglycosid enthaltende liposome zur behandlung von pulmonaren infektionen
US7879351B2 (en) 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
FR2854072B1 (fr) * 2003-04-23 2006-08-04 Centre Nat Rech Scient Vecteur pour administration par voie orale
KR100847607B1 (ko) * 2004-03-23 2008-07-21 신토고교 가부시키가이샤 주형 조형장치 및 이에 사용하는 금형장치
TW201204410A (en) * 2004-04-01 2012-02-01 Oncothyreon Inc Mucinous glycoprotein (MUC-1) vaccine
DE102004018283A1 (de) * 2004-04-15 2005-11-03 Wacker-Chemie Gmbh Verfahren zur kontinuierlichen Herstellung von Silicon Emulsionen
WO2006095798A1 (ja) * 2005-03-09 2006-09-14 Sunstar Inc. フィトステロールを含んだリポソームを含有する抗癌用経口組成物、該リポソームによる癌の予防又は治療
WO2007012191A1 (en) * 2005-07-27 2007-02-01 Protiva Biotherapeutics, Inc. Systems and methods for manufacturing liposomes
ES2798263T3 (es) 2005-12-08 2020-12-10 Insmed Inc Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
US11214476B2 (en) 2006-03-06 2022-01-04 Deka Products Limited Partnership System and method for generating a drive signal
US9146564B2 (en) 2006-03-06 2015-09-29 Deka Products Limited Partnership Product dispensing system
US11906988B2 (en) 2006-03-06 2024-02-20 Deka Products Limited Partnership Product dispensing system
US7740152B2 (en) 2006-03-06 2010-06-22 The Coca-Cola Company Pump system with calibration curve
US10631558B2 (en) 2006-03-06 2020-04-28 The Coca-Cola Company Methods and apparatuses for making compositions comprising an acid and an acid degradable component and/or compositions comprising a plurality of selectable components
US8353619B2 (en) * 2006-08-01 2013-01-15 Covaris, Inc. Methods and apparatus for treating samples with acoustic energy
US8119156B2 (en) * 2006-10-24 2012-02-21 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8071127B2 (en) * 2006-10-24 2011-12-06 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8268347B1 (en) 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US7985058B2 (en) * 2007-01-12 2011-07-26 Mark Gray Method and apparatus for making uniformly sized particles
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
WO2009120247A2 (en) * 2007-12-27 2009-10-01 The Ohio State University Research Foundation Lipid nanoparticle compositions and methods of making and using the same
US9445975B2 (en) 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
WO2010041727A1 (ja) * 2008-10-10 2010-04-15 株式会社リポソーム工学研究所 リポソーム製造装置
WO2010044399A1 (ja) * 2008-10-14 2010-04-22 株式会社リポソーム工学研究所 多機能リポソーム自動製造装置
US20120101148A1 (en) 2009-01-29 2012-04-26 Alnylam Pharmaceuticals, Inc. lipid formulation
NZ594995A (en) 2009-03-12 2013-06-28 Alnylam Pharmaceuticals Inc LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF HUMAN KINESIN FAMILY MEMBER 11 (Eg5) AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) GENES
CA2760776C (en) 2009-05-05 2019-07-09 Alnylam Pharmaceuticals, Inc. Lipid compositions for the delivery of therapeutic agents
CA3045126A1 (en) 2009-05-05 2010-11-11 Arbutus Biopharma Corporation Methods of delivering oligonucleotides to immune cells
CA2764609C (en) 2009-06-10 2018-10-02 Alnylam Pharmaceuticals, Inc. Improved cationic lipid of formula i
AP2015008874A0 (en) 2009-08-14 2015-11-30 Alnylam Pharmaceuticals Inc Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
WO2011139911A2 (en) 2010-04-29 2011-11-10 Isis Pharmaceuticals, Inc. Lipid formulated single stranded rna
CN110123830A (zh) 2010-11-09 2019-08-16 阿尔尼拉姆医药品有限公司 用于抑制Eg5和VEGF基因的表达的脂质配制的组合物和方法
HUE043809T2 (hu) 2011-11-04 2019-09-30 Nitto Denko Corp Eljárás lipid-nukleinsav részecskék steril elõállítására
ES2905368T3 (es) 2012-05-21 2022-04-08 Insmed Inc Sistemas para el tratamiento de infecciones pulmonares
US9415109B2 (en) 2012-07-06 2016-08-16 Alnylam Pharmaceuticals, Inc. Stable non-aggregating nucleic acid lipid particle formulations
WO2014085526A1 (en) 2012-11-29 2014-06-05 Insmed Incorporated Stabilized vancomycin formulations
AU2013355258A1 (en) 2012-12-07 2015-06-11 Alnylam Pharmaceuticals, Inc. Improved nucleic acid lipid particle formulations
CN105143456A (zh) * 2013-03-15 2015-12-09 不列颠哥伦比亚大学 用于转染的脂质纳米粒子和相关方法
MX2016005232A (es) 2013-10-22 2017-01-19 Aradigm Corp Formulaciones liposomicas para inhalacion, modificadas con agente tensoactivo, que proveen un perfil de liberacion tanto inmediata como sostenida.
KR101713886B1 (ko) 2013-12-19 2017-03-10 연세대학교 산학협력단 ＰＲＫ２를 표적으로 하는 Ｃ형 간염 바이러스 치료제 ｓｉＲＮＡ
PL3142643T3 (pl) 2014-05-15 2019-12-31 Insmed Incorporated Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
CN106456547B (zh) * 2014-07-02 2021-11-12 川斯勒佰尔公司 信使rna的包封
US10987048B2 (en) 2014-08-13 2021-04-27 Elwha Llc Systems, methods, and devices to incentivize inhaler use
US10765817B2 (en) 2014-08-13 2020-09-08 Elwha, Llc Methods, systems, and devices related to delivery of alcohol with an inhaler
US10245393B2 (en) 2014-08-13 2019-04-02 Elwha Llc Methods, systems, and devices related to a supplemental inhaler
JP6373749B2 (ja) 2014-12-19 2018-08-15 富士フイルム株式会社 リポソームの製造方法及びリポソーム製造装置
EP3271057B1 (de) * 2015-03-19 2019-09-04 The University of Connecticut Systeme und verfahren zur kontinuierlichen herstellung von liposomen arzneimittelformulierungen
US12491261B2 (en) 2016-10-26 2025-12-09 Acuitas Therapeutics, Inc. Lipid nanoparticle formulations
JP7738979B2 (ja) * 2016-11-10 2025-09-16 トランスレイト バイオ， インコーポレイテッド Ｍｒｎａ担持脂質ナノ粒子を調製する改善されたプロセス
EP3773505A4 (de) 2018-03-30 2021-12-22 Insmed Incorporated Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten
AU2019262117C1 (en) 2018-05-02 2024-12-05 Insmed Incorporated Methods for the manufacture of liposomal drug formulations
EP4613367A1 (de) * 2018-09-21 2025-09-10 Acuitas Therapeutics, Inc. Systeme und verfahren zur herstellung von lipidnanopartikeln und liposomen
CN112955252B (zh) * 2018-10-26 2023-11-21 康涅狄格大学 用于对纳米粒子进行内部和外部修饰的连续处理系统和方法
US12324800B2 (en) 2019-01-24 2025-06-10 CannaClear Inc. Lecithin vesicles
US11154502B2 (en) * 2019-01-24 2021-10-26 CannaClear Inc. Lecithin vesicles for oral delivery
US12201724B2 (en) 2019-01-24 2025-01-21 CannaClear Inc. Lecithin vesicles for oral delivery
DK4182297T3 (da) 2020-07-16 2025-12-01 Acuitas Therapeutics Inc Kationiske lipider til brug i lipid-nanopartikler
EP4359528A1 (de) 2021-06-25 2024-05-01 Alpine Antiviral GmbH Gegen sars-cov-2- und/oder wirtsfaktortranskripte gerichtete sirna-kombinationen
JP2024543826A (ja) 2021-11-03 2024-11-26 レオン－ナノドラッグス ゲーエムベーハー 小液体容積を混合するための装置および方法、ならびに装置の使用
WO2023114943A2 (en) 2021-12-16 2023-06-22 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
EP4526028A1 (de) 2022-09-30 2025-03-26 leon-nanodrugs GmbH Kassettensystem für aseptisches mischverfahren
AU2023348363A1 (en) 2022-09-30 2025-03-20 Leon-Nanodrugs Gmbh Apparatus and method for operating a static mixing device
WO2025221360A1 (en) * 2024-02-15 2025-10-23 Recode Therapeutics, Inc. Systems and methods for generating lipid nanoparticles

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1298194A (en) 1968-11-20 1972-11-29 Agfa Gevaert Improved method for encapsulating aqueous or hydrophilic material, the capsules obtained therewith and their application
JPS4945224B1 (de) 1970-12-14 1974-12-03
DE2357212A1 (de) * 1973-11-16 1975-05-22 Henkel & Cie Gmbh Verfahren und vorrichtung zur kontinuierlichen herstellung von kolloidalen loesungen und emulsionen
US4108115A (en) * 1974-06-07 1978-08-22 Lucas Electrical Company, Limited Fuel injection systems for compression ignition engines
CH588887A5 (de) 1974-07-19 1977-06-15 Battelle Memorial Institute
JPS5186117A (en) 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
AU499635B2 (en) * 1976-02-20 1979-04-26 Thapa Chemical Industry Co Ltd Material mixing apparatus
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
ATE8584T1 (de) 1980-01-16 1984-08-15 Hans Georg Prof. Dr. Weder Verfahren und dialysiereinrichtung zur herstellung von bilayer-vesikeln und verwendung der bilayer-vesikel.
US4452747A (en) * 1982-03-22 1984-06-05 Klaus Gersonde Method of and arrangement for producing lipid vesicles
DE3230289A1 (de) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen Herstellung von pharmazeutischen oder kosmetischen dispersionen
US4551288A (en) 1982-08-16 1985-11-05 Sandoz, Inc. Processes for the preparation of liposome drug delivery systems
US4485054A (en) 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
JPS607932A (ja) 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソーム懸濁液およびその製法
US4532089A (en) 1984-01-14 1985-07-30 Northwestern University Method of preparing giant size liposomes
US4761288A (en) 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
US4737276A (en) * 1984-12-21 1988-04-12 E. I. Du Pont De Nemours And Company Apparatus for manufacturing liposomes
US4781871A (en) * 1986-09-18 1988-11-01 Liposome Technology, Inc. High-concentration liposome processing method
US4752425A (en) * 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
US4855090A (en) 1987-03-13 1989-08-08 Micro-Pak, Inc. Method of producing high aqueous volume multilamellar vesicles
US5474848A (en) 1987-03-13 1995-12-12 Micro-Pak, Inc. Paucilamellar lipid vesicles
US5628936A (en) 1987-03-13 1997-05-13 Micro-Pak, Inc. Hybrid paucilamellar lipid vesicles
US4853228A (en) 1987-07-28 1989-08-01 Micro-Pak, Inc. Method of manufacturing unilamellar lipid vesicles
US5271881A (en) * 1987-09-28 1993-12-21 Redding Bruce K Apparatus and method for making microcapsules
US5013497A (en) * 1988-03-03 1991-05-07 Micro-Pak, Inc. Method and apparatus for producing lipid vesicles
US4895452A (en) * 1988-03-03 1990-01-23 Micro-Pak, Inc. Method and apparatus for producing lipid vesicles
US4935171A (en) * 1989-01-27 1990-06-19 Vestar, Inc. Method for vesicle formation
DE3916465A1 (de) * 1989-05-20 1990-11-22 Bayer Ag Herstellung kugelfoermiger dispersionen durch kristallisation von emulsionen
DE4031094A1 (de) 1990-10-02 1992-04-09 Basf Ag Verfahren zur herstellung von stabilen injizierbaren (beta)-carotin-solubilisaten
JP2729538B2 (ja) * 1991-02-13 1998-03-18 富士写真フイルム株式会社 マイクロカプセルの製造方法
US5474846A (en) * 1993-01-26 1995-12-12 Haldenby; George A. Uniform polymeric coated interior cylinder surface
EP0616801B1 (de) * 1993-03-24 1998-05-27 Novartis AG Verfahren zur Herstellung einer Liposomendispersion im Hochdruckbereich
US5554382A (en) * 1993-05-28 1996-09-10 Aphios Corporation Methods and apparatus for making liposomes
DE69407292T2 (de) * 1993-06-30 1998-06-25 Genentech Inc Verfahren zur herstellung von liposomen
DE4432378A1 (de) * 1994-09-12 1996-03-14 Bayer Ag Injizierbare liposomale Arzneizubereitungen
JP3430787B2 (ja) * 1996-04-02 2003-07-28 ミノルタ株式会社 現像装置
US20040099976A1 (en) * 2000-10-13 2004-05-27 Katsuto Otake Process for producing liposome and apparatus therefor
EP1203614A1 (de) * 2000-11-03 2002-05-08 Polymun Scientific Immunbiologische Forschung GmbH Verfahren und Vorrichtung zur Herstellung von Lipidvesikeln

Also Published As

Publication number Publication date
EP1146959A1 (de) 2001-10-24
US20050196435A1 (en) 2005-09-08
US6855277B2 (en) 2005-02-15
AU756196B2 (en) 2003-01-09
US6534018B1 (en) 2003-03-18
CA2350430A1 (en) 2000-05-25
IL143104A (en) 2005-09-25
EP1146959A4 (de) 2004-12-29
AU1476800A (en) 2000-06-05
IL143104A0 (en) 2002-04-21
JP2002529240A (ja) 2002-09-10
EP1146959B1 (de) 2008-06-04
WO2000029103A1 (en) 2000-05-25
DE69938875D1 (de) 2008-07-17
CA2350430C (en) 2008-06-03
US20030124033A1 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
ATE397488T1 (de) Vorrichtung zur herstellung von liposomen
DE69924682D1 (de) Vorrichtung zur Herstellung von Wasserstoff
DE69927548D1 (de) Vorrichtung zur Herstellung von Dünnfilmen
ATE226949T1 (de) Verfahren zur herstellung von tolterodin
DE69601041D1 (de) Vorrichtung zur Gewinnung von Sauerstoff
DE69601295D1 (de) Vorrichtung zur Gewinnung von Sauerstoff
ATE223383T1 (de) Verfahren zur herstellung von 3-haloalkyl-1h- pyrazole
DE69309763D1 (de) Vorrichtung zur Herstellung von Rohren
DE60028492D1 (de) Vorrichtung zur Herstellung von Dünnfilmen
DE69824481D1 (de) Verfahren zur Herstellung von FET-Bauelementen mit flacher,maskenloser Grabenisolation
DE69434937D1 (de) Verfahren zur Herstellung von Leistungsbauteilen in MOS-Technologie
DE69624976D1 (de) Verfahren zur Herstellung von MOS-Leistungstransistoren
ATE461271T1 (de) Verfahren zur herstellung von l-aminosäure
DE59811911D1 (de) Verfahren zur Herstellung von stabilen, feinteiligen Polymerdispersionen
DE69429023D1 (de) Vorrichtung zur Herstellung von Stempeln
DE59810077D1 (de) Vorrichtung zur erzeugung von plasma
DE69531762D1 (de) Vorrichtung zur Erzeugung von Ozonwasser
DE69916725D1 (de) Vorrichtung zur herstellung von zement
DE69927602D1 (de) Verfahren zur herstellung von vitaminpulvern
ATA138096A (de) Vorrichtung zur gewinnung von biogas
DE68921251D1 (de) Verfahren und Vorrichtung zur Herstellung von Cyanwasserstoff.
DE59500727D1 (de) Vorrichtung zur Herstellung von Aufgussgetränken
ATE385232T1 (de) Verfahren zur herstellung von 3, 3', 6, 6'- tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'- tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
DE59608266D1 (de) Vorrichtung zur herstellung von tabletten
DE59503886D1 (de) Vorrichtung zur herstellung von teigbändern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties